These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21137047)

  • 21. Practical points in urinary proteomics.
    Thongboonkerd V
    J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein mass spectra data analysis for clinical biomarker discovery: a global review.
    Roy P; Truntzer C; Maucort-Boulch D; Jouve T; Molinari N
    Brief Bioinform; 2011 Mar; 12(2):176-86. PubMed ID: 20534688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter- and intra-biobank networks: classification of biobanks.
    Shickle D; Griffin M; El-Arifi K
    Pathobiology; 2010; 77(4):181-90. PubMed ID: 20616613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to dimensionality reduction in proteomic biomarker studies.
    Hilario M; Kalousis A
    Brief Bioinform; 2008 Mar; 9(2):102-18. PubMed ID: 18310106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The challenge of establishing, growing and sustaining a large biobank: a personal perspective.
    McQueen MJ; Keys JL; Bamford K; Hall K
    Clin Biochem; 2014 Mar; 47(4-5):239-44. PubMed ID: 24316099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical, legal, and social implications of biobanks for genetics research.
    Haga SB; Beskow LM
    Adv Genet; 2008; 60():505-44. PubMed ID: 18358331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consistency of a two clinical site sample collection: a proteomics study.
    Wiesner C; Hannum C; Reckamp K; Figlin R; Dubridge R; Roy SM; Lin S; Becker CH; Jones T; Hiller J; Cheville JC; Wilson K
    Proteomics Clin Appl; 2010 Sep; 4(8-9):726-38. PubMed ID: 21137090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Towards a standardization of the tools for the studies of clinical proteomics].
    Lucchi G; Hendra JB; Pecqueur D; Ducoroy P
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():19-22. PubMed ID: 17669348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biobanking of CSF: international standardization to optimize biomarker development.
    Teunissen CE; Tumani H; Engelborghs S; Mollenhauer B
    Clin Biochem; 2014 Mar; 47(4-5):288-92. PubMed ID: 24389077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing and managing a periodontal biobank for research: the sharing of experience.
    Vaithilingam RD; Safii SH; Baharuddin NA; Karen-Ng LP; Saub R; Ariffin F; Ramli H; Sharifuddin A; Hidayat MF; Raman R; Chan YK; Rani NA; Rahim RA; Shahruddin N; Cheong SC; Bartold PM; Zain RB
    Oral Dis; 2015 Jan; 21(1):e62-9. PubMed ID: 24930489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographical focus. Proteomics initiatives in Spain: ProteoRed.
    Paradela A; Escuredo PR; Albar JP
    Proteomics; 2006 Sep; 6 Suppl 2():73-6. PubMed ID: 17031803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biobanking in a constantly developing medical world.
    Artene SA; Ciurea ME; Purcaru SO; Tache DE; Tataranu LG; Lupu M; Dricu A
    ScientificWorldJournal; 2013; 2013():343275. PubMed ID: 24174912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biological sample banks: ethical and legal aspects. General introduction].
    Cambon-Thomsen A
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):99. PubMed ID: 12684565
    [No Abstract]   [Full Text] [Related]  

  • 35. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preanalytical variations of proteic biomarkers].
    Lambert D; Berrahmoune H; Herbeth B; Siest G; Visvikis-Siest S
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():9-12. PubMed ID: 17669346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International efforts to develop biospecimen best practices.
    Vaught JB; Caboux E; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):912-5. PubMed ID: 20233852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ethical and legal aspects of biological sample banks: synthesis, practical questions and proposals].
    Cambon-Thomsen A; Rial-Sebbag E; Duchier J
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):121-6. PubMed ID: 12684568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-analytical issues for testosterone and estradiol assays.
    Raff H; Sluss PM
    Steroids; 2008 Dec; 73(13):1297-304. PubMed ID: 18589466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomics methods and applications for the practicing clinician.
    Reisdorph NA; Reisdorph R; Bowler R; Broccardo C
    Ann Allergy Asthma Immunol; 2009 Jun; 102(6):523-9. PubMed ID: 19558013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.